Cinzia Marchese Selected Research

Cinzia Marchese Research Topics

Disease

21	Neoplasms (Cancer) 10/2023 - 06/2008
7	Rhabdomyosarcoma 10/2022 - 01/2019
5	Sarcoma (Soft Tissue Sarcoma) 10/2022 - 01/2019
4	Embryonal Rhabdomyosarcoma 01/2022 - 10/2017
3	Inflammation (Inflammations) 07/2023 - 01/2020
3	Cicatrix (Scar) 10/2021 - 04/2008
3	Ovarian Neoplasms (Ovarian Cancer) 03/2021 - 01/2020
2	Lymphoma (Lymphomas) 10/2023 - 01/2021
2	Infections 12/2021 - 01/2013
2	Carcinogenesis 10/2021 - 01/2013
2	Ovarian Epithelial Carcinoma 10/2021 - 01/2021
2	Mullerian aplasia 05/2021 - 01/2014
2	Systemic Scleroderma (Systemic Sclerosis) 01/2016 - 01/2013
2	Wounds and Injuries (Trauma) 09/2012 - 01/2012
1	Cholangiocarcinoma 01/2023
1	COVID-19 12/2021
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2021
1	Genomic Instability 01/2021
1	Endometriosis 04/2020
1	Atrial Fibrillation 04/2020
1	Euthyroid Sick Syndromes (Euthyroid Sick Syndrome) 01/2020
1	Pancreatic Neoplasms (Pancreatic Cancer) 06/2019
1	Pancreatic Diseases (Pancreatic Disease) 06/2019
1	Colorectal Neoplasms (Colorectal Cancer) 10/2017
1	Circulating Neoplastic Cells 10/2017
1	Atrophy 09/2014
1	Hyperplasia 01/2013
1	Adenoma (Adenomas) 01/2013
1	Rare Diseases (Rare Disease) 01/2013
1	Papillary Carcinoma 01/2013
1	Fat Necrosis 01/2013
1	Marfan Syndrome (Marfan's Syndrome) 09/2012
1	Vitiligo 05/2012
1	Stomatitis 04/2012
1	Kaposi Sarcoma (Kaposi's Sarcoma) 01/2009
1	Breast Neoplasms (Breast Cancer) 06/2008

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 01/2023 - 01/2013
5	Biomarkers (Surrogate Marker)IBA 12/2021 - 06/2019
4	Messenger RNA (mRNA)IBA 01/2023 - 01/2013
3	MicroRNAs (MicroRNA)IBA 01/2023 - 01/2021
2	Oncogene Proteins (Oncogene Protein)IBA 10/2023 - 10/2022
2	LigandsIBA 10/2023 - 06/2008
2	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 01/2023 - 01/2009
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 08/2020
2	OTX015IBA 03/2021 - 01/2020
2	olaparibIBA 01/2021 - 01/2020
2	SolutionsIBA 01/2013 - 04/2008
1	Inducible T-Cell Co-Stimulator ProteinIBA 02/2024
1	DNA (Deoxyribonucleic Acid)IBA 07/2023
1	MethyltransferasesIBA 07/2023
1	Tyrosine Kinase InhibitorsIBA 01/2023
1	pemigatinibIBA 01/2023
1	oleandrinIBA 01/2022
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2022
1	PBI-05204IBA 01/2022
1	CalcineurinIBA 10/2021
1	CollagenIBA 10/2021
1	RNA (Ribonucleic Acid)IBA 10/2021
1	entinostat (MS 275)IBA 10/2021
1	Histone Deacetylase InhibitorsIBA 10/2021
1	Protein Kinases (Protein Kinase)IBA 05/2021
1	Interleukin-6 (Interleukin 6)IBA 01/2021
1	OligonucleotidesIBA 01/2021
1	CateninsIBA 01/2021
1	cobomarsenIBA 01/2021
1	CytokinesIBA 08/2020
1	Toll-Like Receptor 4IBA 04/2020
1	SubtilisinIBA 04/2020
1	Proprotein Convertases (Pro-Opiomelanocortin Converting Enzyme)IBA 04/2020
1	Neuropilin-1IBA 01/2020
1	Thyroid HormonesIBA 01/2020
1	Prothrombin (Factor II)IBA 06/2019
1	Carcinoembryonic AntigenIBA 06/2019
1	Vitamin K FDA Link 06/2019
1	acarboxyprothrombin (PIVKA)IBA 06/2019
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2019
1	Carboplatin (JM8)FDA LinkGeneric 01/2019
1	Epithelial Cell Adhesion MoleculeIBA 10/2017
1	Indicators and Reagents (Reagents)IBA 10/2017
1	EphrinsIBA 10/2017
1	Erythropoietin FDA Link 10/2017
1	Phosphotransferases (Kinase)IBA 10/2017
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 01/2013
1	Protein Isoforms (Isoforms)IBA 01/2013
1	Therapeutic UsesIBA 04/2012
1	Estrogens (Estrogen)FDA Link 06/2008
1	Tamoxifen FDA LinkGeneric 06/2008
1	Fluorouracil (Carac)FDA LinkGeneric 06/2008

Therapy/Procedure

12	Therapeutics 01/2023 - 01/2012
3	Transplantation 01/2016 - 09/2012
2	Radiotherapy 01/2022 - 08/2020
2	Drug Therapy (Chemotherapy) 01/2021 - 04/2012
1	Intravenous Administration 01/2021
1	Precision Medicine 01/2021
1	Intravenous Injections 01/2021
1	Tissue Transplantation 01/2014
1	Solid-State Lasers 05/2012
1	Dermabrasion 05/2012
1	Chemoradiotherapy 04/2012